A man gives a nasopharyngeal swab for COVID-19 rapid antigen test in New Delhi. File

A male gives a nasopharyngeal swab for COVID-19 rapid antigen test in New Delhi. Submit.|Picture Credit:
Shiv Kumar Pushpakar.

.

.

ICMR has directed ‘strict quick track for all approvals connected to initiation of the medical trial and guarantee that the subject enrolment is initiated no later than 7th July 2020.’.

Looking at launching the country’s very first native COVID-19 vaccine for public health usage newest by August 15, 2020 after completion of all clinical trials, the Indian Council of Medical Research (ICMR) has actually directed “stringent quick track for all approvals associated with initiation of the clinical trial and make sure that the subject enrolment is started no later than 7th July 2020.”

In its letter, the ICMR stated that the Council had partnered with Bharat Biotech International Limited (BBIL) to fast-track scientific trials of the COVID-19 vaccine.

Likewise checked out: Health employees should get COVID-19 vaccine first: PM Modi

Bharat B